ceftolozane 1 GM / tazobactam 0.5 GM Injection
- RxCUI
- 1597615
- RxNorm name
- ceftolozane 1 GM / tazobactam 0.5 GM Injection
- Display name
- ceftolozane 1 GM / tazobactam 0.5 GM Injection
- Full name
- ceftolozane 1 GM / tazobactam 0.5 GM Injection
- Term type
- SY
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:03
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ZERBAXA | CEFTOLOZANE AND TAZOBACTAM | Merck Sharp & Dohme LLC | 70ac1d90-eff3-4f0b-9f46-5846c571b32f | 2026-05-12 | Warnings, Adverse reactions | 1597615 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 70ac1d90-eff3-4f0b-9f46-5846c571b32f | ceftolozane / tazobactam 1.5 GM Injection [PSN] · ceftolozane 1000 MG / tazobactam 500 MG Injection [SCD] · ceftolozane (as ceftolozane sulfate) 1 GM / tazobactam (as tazobactam sodium) 500 MG Injection [SY] · ceftolozane 1 GM / tazobactam 0.5 GM Injection [SY] | 4 | 23 | These highlights do not include all the information needed to use ZERBAXA safely and effectively. See full prescribing information for ZERBAXA. ZERBAXA ® (ceftolozane and tazobactam) for injection, for intravenous use Initial U.S. Approval: 2014 | 20260512 |